Skip to main content

Table 1 Factors potentially associated with HBV and/or HCV infection in haemodialysis centres in Libya

From: Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors

Factors potentially associated with HBV±HCV infection

Sero-positive N=831

Sero-negative N=1551

P- value

 

Number*

Value

Number*

Value

 

Age in years (mean± SD)

831

47.1±14.4

1551

49.5±16.2

<0.001

Males (number and percent)

831

494 (59.4%)

1551

887 (57.2%)

0.296

Whites (number and percent)

805

718 (89.2%)

1528

1312 (85.9%)

0.023

Dialysis vintage in years (median and IQR)

831

6 (3–10)

1551

2 (0.1-3)

<0.001

Previous blood transfusion (number and percent)

597

482 (80.7%)

1010

688 (68.1%)

<0.001

Number of blood transfusions (median and IQR)

597

2 (1–3)

1010

1 (0–3)

<0.001

Previous renal transplant (number and percent)

822

115 (14.0%)

1533

41 (2.7%)

<0.001

Previous dialysis abroad (number and percent)

617

376 (60.9%)

1025

540 (52.7%)

0.001

Previous dialysis in another Libyan centre (number and percent)

612

324 (52.9%)

1018

447 (43.9%)

<0.001

Haemoglobin level in g/dl (mean± SD)

831

10.2±1.9

1551

9.7±1.8

<0.001

Alanine Aminotransferase in IU/L (mean± SD)

269

27.8±20.2

353

19.6±17.9

<0.001

Aspartate Aminotransferase in IU/L (mean± SD)

232

29.6±21.1

328

21.3±20.3

<0.001

Diabetes (number and percent)

831

195 (23.5%)

1551

551 (35.5%)

<0.001

Erythropoietin treatment (number and percent)

604

450 (74.5%)

1059

830 (78.4%)

0.071

  1. *Number of patients with valid data for each variable.